Literature DB >> 14510320

Infections in VLBW infants: studies from the NICHD Neonatal Research Network.

Barbara J Stoll1, Nellie Hansen.   

Abstract

Infection is a serious complication among very low birth weight (VLBW) preterm infants hospitalized in neonatal intensive care units. This article reviews studies from the National Institute of Child Health and Human Development (NICHD) Neonatal Research Network including infection data from observational studies and randomized controlled trials. Blood culture-proven early-onset sepsis (< or = 72 hours) was found in less than 2% of VLBW infants, but was associated with substantial morbidity and mortality. A change in pathogens causing early-onset sepsis among Network patients has been observed over the past decade, with a significant reduction in early-onset group B streptococcal infections, but also a significant increase in early-onset Escherichia coli infections. This change is particularly worrisome, because of the high death rate associated with gram-negative infections, including E coli. Late-onset (> 72 hours) sepsis developed in almost a quarter of infants. The vast majority of infections were caused by gram-positive agents, especially coagulase-negative staphylococci. The risk of late-onset sepsis was inversely related to birth weight and gestational age. Infants with late-onset sepsis were at increased risk for a number of neonatal morbidities, for prolonged hospitalization, and for death. The percentage of deaths attributed to infection increased with increasing postnatal age. The increasing survival of extremely immature infants has resulted in a cohort of infants at prolonged risk for acquired infection. Successful strategies to reduce infections among VLBW infants would improve survival, reduce neonatal morbidity, and reduce the high medical and social costs of VLBW infant care.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14510320     DOI: 10.1016/s0146-0005(03)00046-6

Source DB:  PubMed          Journal:  Semin Perinatol        ISSN: 0146-0005            Impact factor:   3.300


  78 in total

1.  Escherichia coli early-onset sepsis: trends over two decades.

Authors:  Natalia Mendoza-Palomar; Milena Balasch-Carulla; Sabina González-Di Lauro; Maria Concepció Céspedes; Antònia Andreu; Marie Antoinette Frick; Maria Ángeles Linde; Pere Soler-Palacin
Journal:  Eur J Pediatr       Date:  2017-08-02       Impact factor: 3.183

Review 2.  Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants.

Authors:  Jemma Cleminson; Nicola Austin; William McGuire
Journal:  Cochrane Database Syst Rev       Date:  2015-10-24

3.  Survival Without Major Morbidity Among Very Low Birth Weight Infants in California.

Authors:  Henry C Lee; Jessica Liu; Jochen Profit; Susan R Hintz; Jeffrey B Gould
Journal:  Pediatrics       Date:  2020-06-18       Impact factor: 7.124

4.  Relationship between probable nosocomial bacteraemia and organisational and structural factors in UK neonatal intensive care units.

Authors:  G J Parry; J S Tucker; W O Tarnow-Mordi
Journal:  Qual Saf Health Care       Date:  2005-08

5.  Human immunoglobulin G recognizing fibrinogen-binding surface proteins is protective against both Staphylococcus aureus and Staphylococcus epidermidis infections in vivo.

Authors:  John H Vernachio; Arnold S Bayer; Brenda Ames; Dawn Bryant; Bradley D Prater; Peter J Syribeys; Elena L Gorovits; Joseph M Patti
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

6.  Bridging the gaps: getting evidence into practice.

Authors:  William McGuire; Peter W Fowlie
Journal:  CMAJ       Date:  2009-08-10       Impact factor: 8.262

7.  Types of Bacteria associated with Neonatal Sepsis in Al-Thawra University Hospital, Sana'a, Yemen, and their Antimicrobial Profile.

Authors:  Hassan A Al-Shamahy; Amal A Sabrah; Abdul Baki Al-Robasi; Samarih M Naser
Journal:  Sultan Qaboos Univ Med J       Date:  2012-02-07

8.  Pharmacokinetics and safety of caspofungin in neonates and infants less than 3 months of age.

Authors:  Xavier Sáez-Llorens; Mercedes Macias; Padmanabha Maiya; Juan Pineros; Hasan S Jafri; Archana Chatterjee; Gloria Ruiz; Janaki Raghavan; Susan K Bradshaw; Nicholas A Kartsonis; Peng Sun; Kim M Strohmaier; Marissa Fallon; Sheng Bi; Julie A Stone; Joseph W Chow
Journal:  Antimicrob Agents Chemother       Date:  2008-12-15       Impact factor: 5.191

9.  Late-onset sepsis in very low birth weight infants from singleton and multiple-gestation births.

Authors:  Nansi S Boghossian; Grier P Page; Edward F Bell; Barbara J Stoll; Jeffrey C Murray; C Michael Cotten; Seetha Shankaran; Michele C Walsh; Abbot R Laptook; Nancy S Newman; Ellen C Hale; Scott A McDonald; Abhik Das; Rosemary D Higgins
Journal:  J Pediatr       Date:  2013-01-13       Impact factor: 4.406

Review 10.  Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants.

Authors:  David Kaufman; Karen D Fairchild
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.